Benefits
Amplified muscle protein synthesis response
Clinical research shows MyoVera produces a stronger muscle-building response to exercise than protein alone. Amplifies the body's response to existing protein intake and exercise — multiplying the power of each gram of protein consumed. The amplification mechanism is particularly valuable for those with limited protein intake or reduced appetite.
Enhanced amino acid muscle uptake
MyoVera works by enhancing the entry of amino acids (the building blocks that trigger muscle protein synthesis) into muscle. Amino acid uptake is rate-limiting for muscle protein synthesis — improving uptake amplifies anabolic signaling regardless of total protein intake. Mechanism distinguishes from simply adding more protein.
Sarcopenia prevention (healthy aging)
Just because it's typical to lose up to 5% of muscle mass every decade doesn't mean it's inevitable. MyoVera helps maintain strength and performance — making it easier to stay active, capable, and confident as you age. Particularly relevant for the 50% of US adults concerned about muscle health in healthy aging context.
Supports inadequate protein intake populations
Reduced appetite makes it hard to get enough protein — the macronutrient for muscle building and maintenance. A study of adults aged 51+ found nearly half weren't getting enough protein. MyoVera amplifies the muscle-building response to whatever protein IS consumed — particularly valuable for older adults with reduced appetite.
Two-clinical-study evidence base
Supported by two clinical studies demonstrating muscle and strength effects. The patented ingredient is part of Nutrition 21's broader portfolio of clinically-validated muscle and performance ingredients. Research foundation distinguishes from generic chromium products without muscle-specific validation.
Velositol research foundation
MyoVera builds on the Velositol® (amylopectin/chromium complex) research foundation. A preclinical trial demonstrated Velositol added to BCAAs enhanced muscle protein synthesis, insulin signaling, and mTOR signaling pathway activation vs BCAAs alone. The mechanism foundation translates to MyoVera's muscle-amplifying applications.
Strength and performance support
Promotes muscle growth and improves strength by enhancing muscle's ability to use protein efficiently. Multi-parameter benefits including muscle mass, strength, and physical performance support broad applications across athletes, active individuals, and healthy aging populations.
Insulin signaling enhancement (chromium mechanism)
Chromium has well-characterized effects on insulin signaling — and insulin is anabolic for muscle, supporting amino acid uptake into muscle cells. The two forms of chromium in MyoVera work synergistically to enhance insulin-mediated amino acid uptake into muscle vs single chromium form alternatives.
Mechanism of action
Insulin-mediated amino acid uptake
Chromium is well-characterized to enhance insulin signaling. Insulin is anabolic for muscle — driving amino acid uptake into muscle cells. MyoVera's dual-chromium formulation amplifies this insulin-mediated amino acid uptake mechanism. Translates to enhanced substrate availability for muscle protein synthesis.
mTOR pathway activation enhancement
Published preclinical research on Nutrition21's chromium complex (Velositol®) demonstrated mTOR signaling pathway activation enhancement when added to BCAAs. mTOR is the master regulator of muscle protein synthesis. The amplified mTOR activation drives the stronger muscle-building response vs protein alone.
Insulin sensitivity boost
Chromium supports cellular insulin sensitivity — improving the body's response to existing insulin levels. The mechanism supports both glucose disposal and amino acid uptake. MyoVera's two chromium forms may target complementary aspects of insulin signaling for synergistic effects.
Muscle protein synthesis amplification
MyoVera enhances muscle protein synthesis response to protein intake and exercise. The amplification mechanism multiplies the anabolic response from available protein — particularly valuable when protein intake is limited (older adults, reduced appetite populations). Practical mechanism vs simply consuming more protein.
Dual-chromium synergy
Two forms of chromium work synergistically vs single chromium alternatives. Different chromium forms have different absorption profiles and biological effects. Combining forms supports broader bioactivity. The patented combination reflects Nutrition21's clinical research investment in the muscle health applications.
Clinical trials
Two clinical studies supporting MyoVera's muscle protein synthesis amplification and strength benefits. Foundation for the patented ingredient's commercial positioning. Part of Nutrition21's exclusive Healthy Aging Research portfolio.
Adults with muscle health interest including healthy aging populations.
MyoVera produces a stronger muscle-building response to exercise than protein alone. Enhanced amino acid entry into muscle and amplified muscle protein synthesis. Two-study replication strengthens the evidence base. Establishes the muscle and strength optimizer positioning vs generic chromium products.
Published preclinical trial in 24 male Wistar rats (8 weeks old, n=8 per group): Exercise alone, Exercise + BCAAs (0.465 g/kg BW, equivalent to 6 g HED), or Exercise + BCAAs + Velositol® (ACr at 0.155 g/kg BW, 2 g HED). Published in PMC7251890. Foundational mechanism research for Nutrition21's chromium complex applications.
24 male Wistar rats randomly divided into three groups. Preclinical mechanism research.
Addition of amylopectin/chromium complex (ACr/Velositol®) to BCAAs enhanced muscle protein synthesis vs BCAAs alone. Enhanced insulin concentration and mTOR signaling pathway activation. Mechanistic foundation for the Nutrition21 chromium ingredient platform that MyoVera builds upon. Establishes chromium's amplification mechanism for amino acid-driven muscle building.
Class evidence on sarcopenia (age-related muscle loss) providing clinical context for MyoVera's applications. Research includes Srikanthan & Karlamangla (American Journal of Medicine 2014), Harvard Health muscle mass preservation guidance, and von Haehling et al. on cachexia, sarcopenia and muscle (2010).
Various — research on age-related muscle decline patterns and prevention strategies.
Adults typically lose up to 5% muscle mass per decade. 50% of US adults concerned about muscle health for healthy aging. Nearly half of adults aged 51+ not getting enough protein. Reduced appetite limits protein intake. MyoVera's amplification mechanism addresses this exact gap — making existing protein more effective.